Venus Remedies Ltd

At Rs 902.45, sellers were still queuing — but there were no buyers willing to take the other side. Venus Remedies Ltd locked at its lower circuit of 5% on 6 May 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.

At Rs 902.15, sellers were still queuing — but there were no buyers willing to take the other side. Venus Remedies Ltd locked at its lower circuit of 5.0% on 27 Apr 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock.

Venus Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 12 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 April 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

At Rs 949.60, sellers were still queuing — but there were no buyers willing to take the other side. Venus Remedies Ltd locked at its lower circuit of 5.0% on 24 Apr 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand.

At Rs 999.75, sellers were still queuing — but there were no buyers willing to take the other side. Venus Remedies Ltd locked at its lower circuit of 5.0% on 23 Apr 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand.

Surging to an intraday peak of Rs 1119 on 16 Apr 2026, Venus Remedies Ltd has marked a remarkable milestone by hitting a new 52-week high. This achievement caps a spectacular 235.21% rally over the past year, significantly outpacing the Sensex’s modest 1.74% gain, underscoring the stock’s robust momentum amid a mixed broader market backdrop.

Venus Remedies Ltd has reached a new pinnacle in its market journey, touching an all-time high price of Rs.1119 on 16 April 2026. This milestone reflects the company’s robust performance across multiple financial and technical parameters, underscoring its strong position within the Pharmaceuticals & Biotechnology sector.

Venus Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 12 March 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 15 April 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Surging past its previous peaks, Venus Remedies Ltd touched a new 52-week high of Rs 1091.9 on 15 Apr 2026, marking a remarkable rally from its 52-week low of Rs 295. This milestone reflects a sustained momentum driven by a confluence of bullish technical indicators and robust price action over recent sessions.

Venus Remedies Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs. 1,091.9 on 15 Apr 2026, reflecting a remarkable performance trajectory and sustained investor confidence.

A 233.07% stock return in one year. A 182.3% growth in net profit over the same period. The gap between those two numbers is significant but narrower than it might appear at first glance — the market has repriced Venus Remedies Ltd at a higher multiple, but the company’s earnings growth has been robust enough to support much of the rally.

Surging to an all-time high of Rs 1027 on 13 Apr 2026, Venus Remedies Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 225.76% return over the past year. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and improving fundamentals.

Venus Remedies Ltd, a key player in the Pharmaceuticals & Biotechnology sector, achieved a significant milestone on 13 April 2026 as its stock price reached an all-time high. This landmark event reflects the company’s robust financial performance and sustained upward momentum in the market.

At Rs 1,025.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Venus Remedies Ltd locked at its upper circuit of 5.0% on 10 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Surging past its previous peaks, Venus Remedies Ltd touched a new 52-week high of Rs 1022 on 10 Apr 2026, marking a remarkable rally from its 52-week low of Rs 294. This milestone caps a sustained period of price momentum, supported by a confluence of bullish technical indicators and robust quarterly earnings growth.

Venus Remedies Ltd has reached a significant milestone by touching an all-time high price of Rs 1,014 on 10 April 2026, reflecting a strong upward trajectory driven by consistent financial growth and positive market sentiment.

At Rs 1009.15, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Venus Remedies Ltd locked at its upper circuit of 5% on 9 Apr 2026, with buyers queuing and no sellers willing to part with shares.